However, current data concerning bariatric surgery effectiveness in genetic and syndromic obesity, specifically in patients with PWS, are generally based on few case reports, and results are not easy to compare due to differences in surgical procedures and duration of follow-up [49]
We aimed to assess the risk of SIS in new users of GLP-1RA when compared with sodium-glucose cotransporter 2 inhibitors (SGLT-2i) users, prescribed to treat type 2 diabetes in individuals with obesity
Dosing accuracy and compounded preparations The FDA's adverse event reporting data on compounded GLP-1 products includes numerous reports of dosing errors, including cases where patients received substantially higher doses than intended when self-administering from multi-dose vials
Consumers are prioritizing ingredient quality, nutritional value, and satiety per meal, which can make premium smaller portions more profitable than conventional high-volume formats
Our programs combine cutting-edge treatments with weekly follow-ups to monitor your health and maintain forward progress
2024;3(5):e237
